There are
6.4 million psoriasis patients in the United States. Fifty-eight
percent of those with psoriasis experience inadequate
treatment because current major therapies are sometimes ineffective,
unavailable, or unsatisfactory. Current major therapies often help
psoriasis, but can increase skin aging, skin cancer, liver or kidney
toxicity, blood lipids, or blood pressure. We are committed to
helping develop improved therapeutic approaches without the above
drawbacks.
Our Dermatology
faculty have established a full spectrum of projects which
will benefit patients who suffer from psoriasis. Our highly experienced staff takes great pride in providing top quality, well-established therapies with proven efficacy. We work hard to obtain advanced treatments that we believe are safe but have a strong chance of benefit. Thus we can provide early access for our patients to newly developing therapies that are not yet generally available. We are also one of a few centers worldwide with psoriasis awards from the National Institutes of Health, the Dermatology Foundation, and the Department of Veterans Affairs to research how psoriasis lesions are caused, and to develop entirely new ways of treating psoriasis without the side effects of our current therapies.
The Murdough Family Center for Psoriasis,
newly created by a generous gift from the Murdough Foundation,
will allow us to bring benefit to more patients with the disease.
The Murdough Family Center for Psoriasis incorporates both the
psoriasis research and treatment efforts of the medical center,
and creates new community interfaces and a complete approach to
both the mind and the body aspects of psoriasis.
To
receive more information on the Murdough Family Center for Psoriasis,
visit the Center website at www.murdoughpsoriasis.com.
For
questions regarding the Center, please contact:
Minja Griesser, Practice
Administrator
Phone: (216) 368-0533
Email: mag28@case.edu
Back to top
